X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - FINANCIALPOST.COM - A La Une - 15/Sep 12:45

Ipsen provides update on CONTACT-02 Phase III trial in metastatic castration-resistant prostate cancer following final overall survival analysis

Trial investigating Cabometyx® (cabozantinib) in combination with atezolizumab demonstrated a positive trend towards improvement for one of the primary endpoints of overall survival, but did not meet statistical significance Ipsen will not pursue regulatory submissions for the combination regimen in countries where we have commercialization rights (outside of the US and Japan) We remain confident […]

Articles similaires

Sorry! Image not available at this time

Targeted cancer therapies: Getting radioactive atoms to accumulate in tumours

oncologynews.com.au - 12/Sep 14:10

Prostate cancer is the second most common cancer among men worldwide, following lung cancer. In the United States alone, nearly 300,000 new cases are...

Sorry! Image not available at this time

Targeted cancer therapies: Getting radioactive atoms to accumulate in tumours

oncologynews.com.au - 12/Sep 14:10

Prostate cancer is the second most common cancer among men worldwide, following lung cancer. In the United States alone, nearly 300,000 new cases are...

Sorry! Image not available at this time

Doxorubicin + Trabectedin Tied to Increased Survival in Metastatic Leiomyosarcoma

drugs.com - 05/Sep 22:39

THURSDAY, Sept. 5, 2024 -- For patients with metastatic or surgically unresectable leiomyosarcoma, combination therapy with doxorubicin and...

Sorry! Image not available at this time

Datopotamab Deruxtecan Showed Median Overall Survival of 14.6 Months in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer in TROPION-Lung01 Phase III Trial

drugs.com - 09/Sep 09:09

9 September 2024 -- Detailed results from the TROPION-Lung01 Phase III trial showed a clinically meaningful trend toward improving overall survival...

Sorry! Image not available at this time

Datopotamab Deruxtecan Showed Median Overall Survival of 14.6 Months in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer in TROPION-Lung01 Phase III Trial

drugs.com - 09/Sep 09:09

9 September 2024 -- Detailed results from the TROPION-Lung01 Phase III trial showed a clinically meaningful trend toward improving overall survival...

Sorry! Image not available at this time

New cancer drug shows encouraging results in Phase I/II trial

news.medical.net - 14/Sep 08:17

The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial...

Sorry! Image not available at this time

SOLARIS Trial: High-Dose Vitamin D3 in Metastatic Colon Cancer

medindia.net - 16/Sep 11:02

SOLARIS, a phase 3 clinical trial led by Dana-Farber Cancer Institute, tested the addition of high-dose medlinkvitamin D3/medlink to standard...

Sorry! Image not available at this time

SOLARIS Trial: High-Dose Vitamin D3 in Metastatic Colon Cancer

medindia.net - 16/Sep 11:02

SOLARIS, a phase 3 clinical trial led by Dana-Farber Cancer Institute, tested the addition of high-dose medlinkvitamin D3/medlink to standard...

Sorry! Image not available at this time

Prostate cancer doesn’t have to be fatal

e-know.ca - 08/Sep 20:34

Letter to the Editor We expect this year we will see over 24,000 Canadian men die from prostate cancer (PCa).  And the saddest part of...

Sorry! Image not available at this time

Prostate cancer doesn’t have to be fatal

e-know.ca - 08/Sep 20:34

Letter to the Editor We expect this year we will see over 24,000 Canadian men die from prostate cancer (PCa).  And the saddest part of...

Les derniers communiqués